The objective of this report is to examine the development of pharmacovigilance (PV) in Ghana and illustrate the role it plays in the health system, and more recently, during the COVID-19 emergency response...
This study examines the expenditure by Caribbean Community (CARICOM) countries on the delivery of Essential Public Health Services (EPHS), in the context of the global response to COVID-19. In particular...
This report discusses the importance of pharmacovigilance (PV) in contributing to building up resilient health systems. It is based on and summarizes the findings of a review of available literature on...
Building capacity in countries to conduct thorough surveillance of the use of all newly authorized drugs and vaccines, both brand name and generic, is a critical “public good” investment to ensure that...
Medicines, vaccines, medical devices, and blood are commonly used to treat disease. Medicines deserve a special focus because almost any medical visit ends with at least one prescription. So, monitoring...
This report focuses on the Caribbean Public Health Agency (CARPHA), one of the three multi-national public health agencies in the world, that commenced operations on Jan 1, 2013, with the aim of delivering...
The Spanish System of Pharmacovigilance (SSPV) started its activities almost 40 years ago, in 1985. Of particular interest to others considering various options for developing pharmacovigilance systems...
Although indispensable for improving health outcomes, medicines and vaccines or their administration and use can produce adverse effects, requiring continuous vigilance to ensure that the benefits outweigh...
The response of the government of the Republic of Korea to COVID-19 has been heralded as among the most successful. In the first two years of the pandemic, the government was able to keep the size of the...
The ability to oversee and monitor the use of all newly authorized drugs and vaccines, both brand name and generic, is critical to ensure that they work correctly and that their health benefits outweigh...
This report reviews the pharmacovigilance system of the European Union (EU) mapping out its structure and processes with any eye to features that may be of particular interest to decision makers in other...
In this working paper, an exploration of available data and information is conducted and findings presented, to support the view that the dichotomous business model and related harm reduction narrative...
In this working paper, an initial exploration of available data and information is conducted and findings presented, to support the view that the dichotomous business model and related “harm reduction”...
The rise of antimicrobial resistance (AMR), if not stopped, threatens to plunge humanity back into an era of health uncertainty few people alive today can remember. AMR does not follow national borders;...
Con el fin de contribuir en la evaluación de impacto del aumento impositivo de productos del tabaco en México, el equipo del Programa Global de Control del Tabaco del Grupo del Banco Mundial (BM), preparo...
Montenegro became a Party to the WHO Framework Convention on Tobacco Control in 2006 and ratified the Protocol to Eliminate Illicit Trade in Tobacco Products in 2017. Tobacco excise hikes, undertaken in...
Smoking prevalence Tajikistan remains rather moderate. According to the Global Adult Tobacco Survey (GATS) conducted in 2016, smokers constitute 6.3 percent of the adult population of Tajikistan. However...
This brief provides an overview of tobacco control legislation, use, and taxation in the country. Costa Rica ratified the WHO Framework Convention on Tobacco Control in 2008. General Law for the Control...
The brief provides an overview of tobacco control legislation, use, and taxation in the country.